Research English

11-3-095-2558

Developing health care quality indicators and improving the QOF program for the Thai Universal Health Coverage – Part 2

Researchers

Roongnapa Khampang, PhD. Juntana Pattanaphesaj, PhD. Rukmanee Butchon, PhD.

Status

Completed

Published date

-/-

Download research

211-365-2555(4)

Cost utility analysis and budget impact analysis og imiglucerase for treatment of Gaucher disease patients

Researchers

Utsana Tonmukayakul Kittiphong Thiboonboon Pattara Leelahavarong, PhD.

Status

Completed

Published date

-/-

Download research

211-365-2555(2)

Cost-utility analysis of dasatinib and nilotinib for chronic myeloid leukemia patients who fail to respond to first-line treatment with imatinib in Thailand

Researchers

Wantanee Kulpeng Sumalai Sompitak Yot Teerawattananon, PhD.

Status

Completed

Published date

-/-

Download research

211-366-2555(5)

Economic evaluation of treatment for metastatic clear cell renal cell carcinoma

Researchers

Pritaporn Kingkaew, PhD. Warinya Deepana

Status

Completed

Published date

-/-

Download research

211-365-2555(1)

Cost-Utility Analysis and Budget Impact of the Treatment of Patient with Pulmonary Artery Hypertension

Researchers

Watsamon Thongsri Thanaporn Bussabawalai Pattara Leelahavarong, PhD.

Status

Completed

Published date

-/-

Download research

19-374-2556

Assessing the impact of the Thail and-European Unoin free trade agreement on trade and investment in Thailand

Researchers

Inthira Yamabhai, PhD. Kuntika Dumrongprat B.Sc. in Pharm, MIPHE Benjarin Santatiwongchai

Status

Completed

Published date

-/-

Download research

211-365-2555(3)

Analysis of cost-utility and budget impact of providing imatinib and sinitinib for the treatment in patient with unresectable and/or metastatic GIST using societal perspectives

Researchers

Adun Mohara B.Pharm, M.Sc.

Status

Completed

Published date

-/-

Download research

113-007-2556 (4)

Cost-Effectiveness and Budget Impact of the Use of LHRH Analogues Drugs for Treatment of Prostate cancer as an Adjuvant Therapy and for Metastatic Disease

Researchers

Watsamon Thongsri Naiyana Praditsitthikorn, PhD. Tanunya Koopitakkajorn, B. (Pharm), M.Sc. (Pharm)

Status

Completed

Published date

-/-

Download research

011-377-2556

Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in HIV Patients with Chronic Hepatitis C Co-Infection

Researchers

Kuntika Dumrongprat B.Sc. in Pharm, MIPHE Pritaporn Kingkaew, PhD.

Status

Completed

Published date

-/-

Download research

011-377-2556

Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 6

Researchers

Assoc. Prof. Nattiya Kapol Surasit Lochid-amnuay Yot Teerawattananon, PhD.

Status

Completed

Published date

-/-

Download research

011-377-2556

Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1

Researchers

Assoc. Prof. Nattiya Kapol Surasit Lochid-amnuay Yot Teerawattananon, PhD.

Status

Completed

Published date

-/-

Download research

11-3-089-2557(1)

A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib

Researchers

Pritaporn Kingkaew, PhD. Thanthima Suwanthawornkul Kittiphong Thiboonboon

Status

Completed

Published date

-/-

Download research

Search for Research Projects and Papers